Advances in Precision-Based Cancer Prevention and Detection

On October 27th, 2015, posted in: Cancer 101 by

More than 1.6 million new cancer cases are expected to be diagnosed in the United States in 2015. However, according to the American Association for Cancer Research’s Cancer Progress Report 2015, an estimated 50 percent of the 589,430 U.S. cancer deaths expected to occur in 2015 are attributable to preventable causes. Scientists have identified numerous means to avoid or control known cancer-causing factors, including finding pre-cancerous conditions that may become cancer, changes in diet and lifestyle, mitigating environmental risk factors, and utilizing chemoprevention medicines to prevent cancer from forming or to treat a precancerous condition.

Rapid advances in early cancer detection, when cancer treatments are most effective, are saving lives. New and innovative forms of early cancer detection are harnessing advances in personalized medicine to identify cancers at their earliest stages based upon the individual characteristics of each patient. Today, effective screening strategies not only involve existing techniques, including those for breast, lung and colorectal cancer, but also a complementary understanding of the biology of the disease. For example, clinical trials have moved forward to test biomarkers for the early detection of liver, bladder, lung, mesothelioma, and prostate cancer. Groundbreaking forms of imaging now map tissue biochemistry, making it a potentially powerful surveillance tool for early cancer detection.

These are but a few of the new methods scientists and clinicians are utilizing to revolutionize precision-based cancer research and treatment. To learn more about these and other exciting developments in precision cancer research, we cordially invite you to attend this important briefing.

Speakers include:

Wendy K.D. Selig, President, National Coalition for Cancer Research; Founder and Chief Executive Officer, WS Collaborative;

Sudhir Srivastava [Click to view presentation], Ph.D., MPH, Chief, Cancer Biomarkers Research Group, National Cancer Institute.

Daniel Crichton [Click to view presentation], B.S., M.S., Manager, Principal Investigator, NASA Jet Propulsion Laboratory. Mr. Crichton is also a Principal Investigator of data systems for the NCI Early Detection Research Network;

Mitchell D. Schnall [Click to view presentation], M.D., Ph.D., Chairman, Department of Radiology, University of Pennsylvania;

Clifford A. Hudis, M.D. [Click to view presentation], Chief, Breast Medicine Service, and Vice President for Government Relations and Chief Advocacy Officer, Memorial Sloan Kettering Cancer Center; and

Carolyn R. Aldigé [Click to view presentation], President and Founder, Prevent Cancer Foundation

No Responses to “Advances in Precision-Based Cancer Prevention and Detection”

Leave a Reply